How to buy Heat Biologics (HTBX) shares in Australia
Learn how to easily invest in Heat Biologics shares.
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Heat Biologics Inc is a biotechnology business with stocks listed in the US. Heat Biologics shares (HTBX) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was US$3.93 – a decrease of 9.66% over the previous week. Here's how to invest if you're based in Australia.
How to buy shares in Heat Biologics
- Compare share trading platforms. To buy shares in a US company from Australia you'll need to find a trading platform that offers access to US stock markets. If you're just starting out, look for a platform with low brokerage and foreign exchange fees.
- Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and tax file number. Fund your account with a bank transfer, credit card or debit card.
- Search for Heat Biologics. Find the share by name or ticker symbol: HTBX. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Heat Biologics reaches your desired price. To spread out your risk, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At last close price of US$4.17, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs. You may be able to buy a fractional share of Heat Biologics, depending on your broker.
- Check in on your investment. Congratulations, you own a part of Heat Biologics. Optimise your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.
What's in this guide?
Heat Biologics stock price (NASDAQ:HTBX)Use our graph to track the performance of HTBX stocks over time.
Heat Biologics shares at a glance
|52-week range||US$3.9198 - US$17|
|50-day moving average||US$5.3458|
|200-day moving average||US$6.546|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||US$-1.152|
Where to buy Heat Biologics stock
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
Is it a good time to buy Heat Biologics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Considering buying Heat Biologics shares?Before you consider Heat Biologics, you'll want to hear this.
Ticker Nerd uses advanced software to track hundreds of signals and data points to find stocks before they blow up. You can get the next two hot stocks they find sent to your inbox for free.
Show me how
Heat Biologics price performance over time
|1 week (2021-11-29)||-9.66%|
|1 month (2021-11-05)||-26.54%|
|3 months (2021-09-03)||-39.82%|
|6 months (2021-06-04)||-38.98%|
|1 year (2020-12-04)||-47.04%|
|2 years (2019-12-06)||24.76%|
|3 years (2018-12-06)||-57.79%|
|5 years (2016-12-06)||-53.21%|
Stocks similar to Heat Biologics
Heat Biologics financials
|Revenue TTM||US$2.1 million|
|Gross profit TTM||US$-9,990,926|
|Return on assets TTM||-13.53%|
|Return on equity TTM||-23.16%|
|Market capitalisation||US$105.9 million|
TTM: trailing 12 months
Heat Biologics share dividends
We're not expecting Heat Biologics to pay a dividend over the next 12 months.
Have Heat Biologics's shares ever split?
Heat Biologics's shares were split on a 1:7 basis on 10 December 2020. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Heat Biologics shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Heat Biologics shares which in turn could have impacted Heat Biologics's share price.
Heat Biologics share price volatility
Over the last 12 months, Heat Biologics's shares have ranged in value from as little as US$3.9198 up to US$17. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Heat Biologics's is 0.4379. This would suggest that Heat Biologics's shares are less volatile than average (for this exchange).
Heat Biologics overview
Heat Biologics, Inc., a biopharmaceutical company, engages in the development of immunotherapies to activate patient's immune system against cancer through T-cell activation and expansion. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating platform that functions as an immune activator to stimulate and expand T-cells; and ComPACT, which delivers antigen driven T-cell activation and specific co-stimulation in a single product. The company develops HS-110, which is in phase II clinical trials to treat patients with advanced non-small cell lung cancer; and HS-130 that is in phase I clinical trial for the treatment of advanced solid tumors. Its preclinical stage products include PTX-35, a humanized affinity matured monoclonal antibody, which is a functional agonist of human TNFRSF25; TNFRSF25 modulators for various immunotherapy approaches; and COVID-19 vaccine. Heat Biologics, Inc. has collaboration with Waisman Biomanufacturing to manufacture COVID-19 Vaccine. The company was incorporated in 2008 and is headquartered in Morrisville, North Carolina.
Heat Biologics in the news
Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine Platform Targeting Known and Unknown Emerging Biological Threats
HEAT BIOLOGICS, INC. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
HTBX: Third Quarter Results
Frequently asked questions
More guides on Finder
How to invest in the Allup Silica IPO
Everything we know about the Allup Silica IPO, plus information on how to buy in.
The best products to achieve the clean beauty look
From where the no-makeup makeup look meets the model off duty vibe, we've put together a range of no-fuss products you'll love.
Where to watch Moulin Rouge! online in Australia
Every man wanted her – 1 man dared to love her.
How to watch Man United vs Arsenal Premier League live and match preview
Manchester United are scrambling to stay in touch with the top 4 as they host Arsenal this week
12-day advent calendars you can still get before Christmas
From toys to socks to beauty items, these are the top 12-day advent calendars you can still enjoy in the lead up to Christmas.
McDonald’s (MCD) share price, company profile and news
Steps to owning and managing McDonald's shares from in Australia.
Reputation & Christmas parties: Why I won’t be having a festive celebration this year
Reputation + Christmas parties: could it be the potential volcano erupting leaving rands, families and individuals to deal with the fallout?
Pay-as-you-groan: On-demand insurance that pays you $2K for a broken arm
Insurtech Flip has shaken up the insurance industry by launching the first on-demand injury cover in the country.
How to invest in the Qualitas Limited IPO
Everything we know about the Qualitas Limited IPO, plus information on how to buy in.
Ask an Expert